1. Tao, W., Xu, C.,Ding, Q., Li, R., Xiang, Y., Chung, J. and Zhong, J., A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.Virology395: 67-76 (2009)
2. Ding, Q., Huang, B., Lu, J., Liu, Y-J. and Zhong, J., Hepatitis C virus NS3-4A protease blocks IL28 production.European Journal of Immunology42:2374-2382 (2012)
3. Ding, Q.*, Cao, X.*, Lu, J., Huang,B., Liu, Y-J., Kato, N., Shu H-B., and Zhong, J., Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.Journal of Hepatology59:52-58 (2013)
4. Cao, X.*,Ding, Q.*, Lu, J., Huang, B., Zhao, Y., Niu, J., Liu, YJ., and Zhong, J. MDA5 plays a critical role in interferon response during hepatitis C virus infection.Journal of Hepatology62: 771-778 (2015) (C.X. and Q.D. are co-fist authors)
5. von Schaewen, M.,Ding, Q., and Ploss, A. Visualizing Hepatitis C virus infection in humanized mice.J Immunol Methods410: 50-59(2014)
6. Ding, Q., von Schaewen, M., and Ploss, A. The impact of hepatitis C virus entry on viral tropism.Cell Host & Microbe16: 562-568 (2014)
7. Douam, F, Gaska, JM, Winer, BY,Ding, Q,von Schaewen, M, and Ploss, A. Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.Annual Review of Genetics49, 21-45 (2015)
8. Douam, F. *,Ding, Q.*, and Ploss, A. Recent advances in understanding hepatitis C.F1000Research2016. 5 (F1000 Faculty Rev):131 (D.F. and Q.D. are co-first authors)
9. Winer, B.,Ding, Q.,Gaska, J., and Ploss, A. In vivo models of hepatitis B and C virus infection.FEBS Letterdoi:10.1002/1873-3468.12157 (2016)
10.Ding, Q.,von Schaewen M., Hrebikova, G., Heller, B., Sandmann, L., Plaas, M., and Ploss, A.Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo.Journal of Virology91:e01799-16 (2017)
11.Ding, Q.,Heller, B., Capuccino, J MV., Song, B., Nimgaonkar, I., Hrebikova, G., Contreras, J., and Ploss, A. Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles.Proc Natl Acad Sci U S A114(5): 1147-1152 (2017)
12. Douam, F., Hrebikova,G., Albrecht, Y., Sellau, J., Sharon,Y.,Ding, Q.,and Ploss, A.Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome.Nature Communication8:14781 (2017)
13. Nimagaonkar, I.,Ding, Q.Schwartz, R.,and Ploss, A. Hepatitis E: advances and challenges.Nature Reviews Gastroenterology & Hepatology15, 96–110 (2018)
14.Douam, F., Fusil. F., Enguehard, M., Dib.L., Nadalin.F., Schwaller.L., Hrebikova. G., Mancip, J., Mailly. L., Montserret. R.,Ding, Q., Maisse. C., Carlot. E., Verhoeyen.E., Baumert. T., Ploss A., Carbone A., Cosset.F., and Lavillette.D. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.PLoS pathogens14 (3), e1006908 (2018)
15.Liang, Y*., Cao, X*.,Ding, Q., Zhao, Y., He, Z., and Zhong, J. HCV NS4B induces the degradation of TRIF to inhibit TLR3 mediated interferon signaling pathway.PLoS pathogens14 (5), e1007075 (2018)
16.Ding, Q.Nimagaonkar, I., Bron, Y.,Heller, B.,Schwartz, R.,and Ploss, A.Identification of the intragenomic promoter controlling hepatitis E virus subgenomic RNA transcription.mBio9 (3), e00769-18(2018)
17.Ding, Q.Graemespacher, J., Winer, B., Heller, B., Douam, F., Wei, L., Muir,T.and Ploss, A. Species-specific disruption of antiviral cellular defenses by the Zika virus NS2B3 protease.Proc Natl Acad Sci U S A 115(27):E6310-E6318 (2018)
18. Gaska, J.,Ding, Q., and Ploss, A. Mouse models for studying HCV vaccines and therapeutic antibodies.Methods in Molecular Biology(2017).In Press
19.Bron, Y.,Ding, Q.,Douam, F., Moscona., A., Porotto, M.,Ploss, A., and Schwartz, R. Multiplexed detection of viral DNAs, RNAs and proteins in single cells. 2018Submit
* These authors contributed equally.
